Business Context and Reporting Period
This Form 8-K was filed by BioRestorative Therapies, Inc. on December 19, 2019, reporting events occurring between December 19 and December 23, 2019. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transactions
- Debt Restructuring: The Company extended the due date for two promissory notes from December 31, 2019, to January 31, 2020.
- Note 1: $175,000 principal held by Director John M. Desmarais.
- Note 2: $500,000 principal held by a trust for the benefit of Mr. Desmarais' immediate family.
- Equity Issuance: The Company issued 15,746,926 shares of common stock to settle outstanding indebtedness totaling $100,993 (inclusive of accrued interest).
- Liquidity and Cash Flow: The filing does not provide specific cash flow, revenue, or liquidity metrics. The debt-for-equity swap indicates a strategy to reduce cash outflow obligations.
Material Changes
The primary material changes involve the capital structure and debt maturity profile:
- Debt Maturity Extension: $675,000 in related-party debt was deferred by one month.
- Dilution: Significant issuance of common stock (15.7 million shares) occurred to extinguish approximately $101,000 in debt.
Guidance, Risks, and Unusual Items
Unregistered Sales: The stock issuance was conducted under Section 4(a)(2) and Section 3(a)(9) of the Securities Act of 1933, relying on exemptions for transactions not involving a public offering and exchanges with existing security holders. The Company believes all investors were accredited.
Risks: The extension of debt maturities and the conversion of debt to equity suggest potential liquidity constraints. The filing does not provide forward-looking guidance or specific risk factors beyond the immediate transaction details.
Investor Verification Checklist
- Verify the total outstanding debt remaining after the $100,993 settlement and the $675,000 extension.
- Confirm the impact of the 15,746,926 new shares on existing shareholder dilution.
- Review the Company's cash position to assess the necessity of the debt extensions.
- Check for any subsequent filings regarding the repayment of the extended notes in January 2020.